Nexavar

In the US, Nexavar (sorafenib systemic) is a member of the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors and is used to treat Hepatic Tumor, Hepatocellular Carcinoma, Renal Cell Carcinoma and Thyroid Cancer.

US matches:

• Nexavar

UK matches:

• Nexavar 200mg film-coated tablets (SPC)

Ingredient matches for Nexavar

Sorafenib

Sorafenib is reported as an ingredient of Nexavar in the following countries:

• Czech Republic


• Greece


• Slovenia

Sorafenib tosylate (a derivative of Sorafenib) is reported as an ingredient of Nexavar in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Belize


• Canada


• Chile


• Costa Rica


• Croatia (Hrvatska)


• Denmark


• Dominican Republic


• El Salvador


• Finland


• France


• Germany


• Guatemala


• Honduras


• Hungary


• Indonesia


• Ireland


• Italy


• Luxembourg


• Mexico


• Netherlands


• Nicaragua


• Norway


• Panama


• Slovakia


• South Africa


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

Sunitinib

Sunitinib malate (a derivative of Sunitinib) is reported as an ingredient of Nexavar in the following countries:

• New Zealand

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.